Abstract |
Amino acid sequences containing the palindromic tripeptide RER, matching amino acids 328-330 of the amyloid precursor protein APP, when injected intracerebrally prior to or just after training, protect against memory loss induced by amyloid-beta (A beta) in a one-trial passive avoidance task in the young chick. RER also acts as a cognitive enhancer, strengthening memory for a weak version of the task. N-terminal acylation of RER protects it against rapid degradation, and AcRER is effective in restoring memory if administered peripherally. Biotinylated RER binds to chick neuronal perikarya in an APP-displaceable manner via 66 and approximately 110 kDa neuronal cell membrane proteins. We suggest that RER binding is likely to exert effects on memory retention via receptor-mediated events that include activation of second messenger pathways. These findings suggest that RER and its derivatives may offer a novel approach to enhancing the neuroprotective effects of APP and alleviating the effects of memory loss in the early stages of Alzheimer's disease.
|
Authors | R Mileusnic, C L Lancashire, S P R Rose |
Journal | The European journal of neuroscience
(Eur J Neurosci)
Vol. 19
Issue 7
Pg. 1933-8
(Apr 2004)
ISSN: 0953-816X [Print] France |
PMID | 15078567
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Amyloid beta-Peptides
- Amyloid beta-Protein Precursor
- Glial Fibrillary Acidic Protein
- Nootropic Agents
- Oligopeptides
- Peptide Fragments
- amyloid beta-protein (12-28)
- Glutamic Acid
- Phosphopyruvate Hydratase
|
Topics |
- Amnesia
(chemically induced, drug therapy)
- Amyloid beta-Peptides
- Amyloid beta-Protein Precursor
(chemistry, metabolism)
- Animals
- Animals, Newborn
- Avoidance Learning
(drug effects)
- Binding Sites
- Binding, Competitive
- Biotinylation
(methods)
- Blotting, Western
(methods)
- Cell Count
(methods)
- Cell Membrane
(drug effects)
- Chickens
- Dose-Response Relationship, Drug
- Glial Fibrillary Acidic Protein
(metabolism)
- Glutamic Acid
(pharmacology)
- Immunohistochemistry
(methods)
- Injections, Intraventricular
(methods)
- Memory Disorders
(prevention & control)
- Nootropic Agents
(therapeutic use)
- Oligopeptides
(therapeutic use)
- Peptide Fragments
(pharmacology)
- Phosphopyruvate Hydratase
(metabolism)
- Prosencephalon
(cytology, drug effects)
|